Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography.

Deschasaux M, Bouter KE, Prodan A, Levin E, Groen AK, Herrema H, Tremaroli V, Bakker GJ, Attaye I, Pinto-Sietsma SJ, van Raalte DH, Snijder MB, Nicolaou M, Peters R, Zwinderman AH, Bäckhed F, Nieuwdorp M.

Nat Med. 2018 Oct;24(10):1526-1531. doi: 10.1038/s41591-018-0160-1. Epub 2018 Aug 27.

PMID:
30150717
2.

Study Design and qPCR Data Analysis Guidelines for Reliable Circulating miRNA Biomarker Experiments: A Review.

de Ronde MWJ, Ruijter JM, Moerland PD, Creemers EE, Pinto-Sietsma SJ.

Clin Chem. 2018 Sep;64(9):1308-1318. doi: 10.1373/clinchem.2017.285288. Epub 2018 Jun 14. Review.

PMID:
29903876
3.

Elevated lipoprotein(a) levels are associated with coronary artery calcium scores in asymptomatic individuals with a family history of premature atherosclerotic cardiovascular disease.

Verweij SL, de Ronde MWJ, Verbeek R, Boekholdt SM, Planken RN, Stroes ESG, Pinto-Sietsma SJ.

J Clin Lipidol. 2018 May - Jun;12(3):597-603.e1. doi: 10.1016/j.jacl.2018.02.007. Epub 2018 Feb 16.

PMID:
29550494
4.

Small sample sizes in high-throughput miRNA screens: A common pitfall for the identification of miRNA biomarkers.

Kok MGM, de Ronde MWJ, Moerland PD, Ruijter JM, Creemers EE, Pinto-Sietsma SJ.

Biomol Detect Quantif. 2017 Dec 18;15:1-5. doi: 10.1016/j.bdq.2017.11.002. eCollection 2018 May.

5.

Prognostic value of circulating microRNAs on heart failure-related morbidity and mortality in two large diverse cohorts of general heart failure patients.

Bayés-Genis A, Lanfear DE, de Ronde MWJ, Lupón J, Leenders JJ, Liu Z, Zuithoff NPA, Eijkemans MJC, Zamora E, De Antonio M, Zwinderman AH, Pinto-Sietsma SJ, Pinto YM.

Eur J Heart Fail. 2018 Jan;20(1):67-75. doi: 10.1002/ejhf.984. Epub 2017 Sep 26.

PMID:
28949058
6.

High miR-124-3p expression identifies smoking individuals susceptible to atherosclerosis.

de Ronde MWJ, Kok MGM, Moerland PD, Van den Bossche J, Neele AE, Halliani A, van der Made I, de Winther MPJ, Meijers JCM, Creemers EE, Pinto-Sietsma SJ.

Atherosclerosis. 2017 Aug;263:377-384. doi: 10.1016/j.atherosclerosis.2017.03.045. Epub 2017 Apr 5.

7.

Practical data handling pipeline improves performance of qPCR-based circulating miRNA measurements.

de Ronde MWJ, Ruijter JM, Lanfear D, Bayes-Genis A, Kok MGM, Creemers EE, Pinto YM, Pinto-Sietsma SJ.

RNA. 2017 May;23(5):811-821. doi: 10.1261/rna.059063.116. Epub 2017 Feb 15.

8.

Circulating microRNA biomarkers for cardiovascular risk prediction: are we approaching clinical application?

de Ronde MW, Pinto YM, Pinto-Sietsma SJ.

Ann Transl Med. 2016 Dec;4(24):490. doi: 10.21037/atm.2016.12.05. No abstract available.

9.

Association of Family History With Cardiovascular Disease in Hypertensive Individuals in a Multiethnic Population.

Valerio L, Peters RJ, Zwinderman AH, Pinto-Sietsma SJ.

J Am Heart Assoc. 2016 Dec 21;5(12). pii: e004260. doi: 10.1161/JAHA.116.004260.

10.

Coronary artery calcification score as tool for risk assessment among families with premature coronary artery disease.

Mulders TA, Taraboanta C, Franken LC, van Heel E, Klass G, Forster BB, Arad Y, Boekholdt SM, Groenink M, Fröhlich J, Guerci AD, Stroes ES, Pinto-Sietsma SJ.

Atherosclerosis. 2016 Feb;245:155-60. doi: 10.1016/j.atherosclerosis.2015.12.008. Epub 2015 Dec 11.

PMID:
26724526
11.

Low miR-19b-1-5p expression in isolated platelets after aspirin use is related to aspirin insensitivity.

Kok MG, Mandolini C, Moerland PD, de Ronde MW, Sondermeijer BM, Halliani A, Nieuwland R, Cipollone F, Creemers EE, Meijers JC, Pinto-Sietsma SJ.

Int J Cardiol. 2016 Jan 15;203:262-3. doi: 10.1016/j.ijcard.2015.10.098. Epub 2015 Oct 23. No abstract available.

PMID:
26519680
12.

Circulating MicroRNAs Characterizing Patients with Insufficient Coronary Collateral Artery Function.

Hakimzadeh N, Nossent AY, van der Laan AM, Schirmer SH, de Ronde MW, Pinto-Sietsma SJ, van Royen N, Quax PH, Hoefer IE, Piek JJ.

PLoS One. 2015 Sep 2;10(9):e0137035. doi: 10.1371/journal.pone.0137035. eCollection 2015.

13.

Normalization panels for the reliable quantification of circulating microRNAs by RT-qPCR.

Kok MG, Halliani A, Moerland PD, Meijers JC, Creemers EE, Pinto-Sietsma SJ.

FASEB J. 2015 Sep;29(9):3853-62. doi: 10.1096/fj.15-271312. Epub 2015 May 28.

PMID:
26023181
14.

Individual with subclinical atherosclerosis have impaired proliferation of blood outgrowth endothelial cells, which can be restored by statin therapy.

Martin-Ramirez J, Kok MG, Hofman M, Bierings R, Creemers EE, Meijers JC, Voorberg J, Pinto-Sietsma SJ.

PLoS One. 2014 Jun 23;9(6):e99890. doi: 10.1371/journal.pone.0099890. eCollection 2014.

15.

Individuals with coronary artery disease at a young age and features of the metabolic syndrome have an increased prothrombotic potential.

Kok MG, Meijers JC, Pinto-Sietsma SJ.

Thromb Haemost. 2014 Mar 3;111(3):458-64. doi: 10.1160/TH13-07-0587. Epub 2013 Dec 5.

PMID:
24306178
16.

Non-invasive assessment of microvascular dysfunction in families with premature coronary artery disease.

Mulders TA, Nieuwdorp M, Stroes ES, Vink H, Pinto-Sietsma SJ.

Int J Cardiol. 2013 Oct 12;168(5):5026-8. doi: 10.1016/j.ijcard.2013.07.166. Epub 2013 Jul 25. No abstract available.

PMID:
23968713
17.

A novel lamin A/C mutation in a Dutch family with premature atherosclerosis.

Weterings AA, van Rijsingen IA, Plomp AS, Zwinderman AH, Lekanne Deprez RH, Mannens MM, van den Bergh Weerman MA, van der Wal AC, Pinto-Sietsma SJ.

Atherosclerosis. 2013 Jul;229(1):169-73. doi: 10.1016/j.atherosclerosis.2013.04.016. Epub 2013 Apr 20.

PMID:
23659872
18.

The author's reply.

Mulders TA, Pinto-Sietsma SJ.

Heart. 2013 Jan;99(1):66-7. doi: 10.1136/heartjnl-2012-302440. No abstract available.

PMID:
23250783
19.

Lamin A/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complications.

van Rijsingen IA, Bakker A, Azim D, Hermans-van Ast JF, van der Kooi AJ, van Tintelen JP, van den Berg MP, Christiaans I, Lekanne Dit Deprez RH, Wilde AA, Zwinderman AH, Meijers JC, Grootemaat AE, Nieuwland R, Pinto YM, Pinto-Sietsma SJ.

Int J Cardiol. 2013 Sep 20;168(1):472-7. doi: 10.1016/j.ijcard.2012.09.118. Epub 2012 Oct 14.

20.

APOE1 mutation in a patient with type III hyperlipoproteinaemia: detailed genetic analysis required.

Visser ME, Dallinga-Thie GM, Pinto-Sietsma SJ, Defesche JC, Stroes ES, van der Valk PR.

Neth J Med. 2012 Aug;70(6):278-80.

21.

Asymptomatic individuals with a positive family history for premature coronary artery disease and elevated coronary calcium scores benefit from statin treatment: a post hoc analysis from the St. Francis Heart Study.

Mulders TA, Sivapalaratnam S, Stroes ES, Kastelein JJ, Guerci AD, Pinto-Sietsma SJ.

JACC Cardiovasc Imaging. 2012 Mar;5(3):252-60. doi: 10.1016/j.jcmg.2011.11.014.

22.

Monocyte gene expression signature of patients with early onset coronary artery disease.

Sivapalaratnam S, Basart H, Watkins NA, Maiwald S, Rendon A, Krishnan U, Sondermeijer BM, Creemers EE, Pinto-Sietsma SJ, Hovingh K, Ouwehand WH, Kastelein JJ, Goodall AH, Trip MD.

PLoS One. 2012;7(2):e32166. doi: 10.1371/journal.pone.0032166. Epub 2012 Feb 21.

23.

Arterial stiffness is increased in families with premature coronary artery disease.

Mulders TA, van den Bogaard B, Bakker A, Trip MD, Stroes ES, van den Born BJ, Pinto-Sietsma SJ.

Heart. 2012 Mar;98(6):490-4. doi: 10.1136/heartjnl-2011-300999. Epub 2011 Dec 22.

PMID:
22194150
24.

Platelets in patients with premature coronary artery disease exhibit upregulation of miRNA340* and miRNA624*.

Sondermeijer BM, Bakker A, Halliani A, de Ronde MW, Marquart AA, Tijsen AJ, Mulders TA, Kok MG, Battjes S, Maiwald S, Sivapalaratnam S, Trip MD, Moerland PD, Meijers JC, Creemers EE, Pinto-Sietsma SJ.

PLoS One. 2011;6(10):e25946. doi: 10.1371/journal.pone.0025946. Epub 2011 Oct 13.

25.

A positive family history for premature cardiovascular disease identifies patients prone to recurrent arterial thrombotic events.

Mulders TA, Maurissen LF, Meyer Z, Hameeteman M, van der Donk C, Kroon AA, Ferreira I, Stehouwer CD, Hackeng TM, Pinto-Sietsma SJ.

Eur J Prev Cardiol. 2012 Dec;19(6):1465-73. doi: 10.1177/1741826711422989. Epub 2011 Sep 13.

PMID:
21914686
26.

Prognosis of patients with haematological malignancies admitted to the intensive care unit: Sequential Organ Failure Assessment (SOFA) trend is a powerful predictor of mortality.

Geerse DA, Span LF, Pinto-Sietsma SJ, van Mook WN.

Eur J Intern Med. 2011 Feb;22(1):57-61. doi: 10.1016/j.ejim.2010.11.003. Epub 2010 Dec 8.

PMID:
21238895
27.

Advances in cardiovascular research. 15th Annual Meeting of the European Council for Cardiovascular Research (ECCR). La Colle sur Loup, France, 8–10 October 2010.

Steckelings UM, De Mey JG, Pinto-Sietsma SJ, Henrion D, Unger T.

Expert Rev Cardiovasc Ther. 2011 Jan;9(1):21-5. doi: 10.1586/erc.10.178.

PMID:
21166526
28.

Patients with premature cardiovascular disease and a positive family history for cardiovascular disease are prone to recurrent events.

Mulders TA, Meyer Z, van der Donk C, Kroon AA, Ferreira I, Stehouwer CD, Pinto-Sietsma SJ.

Int J Cardiol. 2011 Nov 17;153(1):64-7. doi: 10.1016/j.ijcard.2010.08.040. Epub 2010 Sep 9.

PMID:
20826021
29.

Birth weight and creatinine clearance in young adult twins: influence of genetic, prenatal, and maternal factors.

Gielen M, Pinto-Sietsma SJ, Zeegers MP, Loos RJ, Fagard R, de Leeuw PW, Beunen G, Derom C, Vlietinck R.

J Am Soc Nephrol. 2005 Aug;16(8):2471-6. Epub 2005 Jun 8.

30.

Role of the endothelin-1 gene locus for renal impairment in the general nondiabetic population.

Pinto-Sietsma SJ, Herrmann SM, Schmidt-Petersen K, Niu T, Hillege HL, Janssen WM, de Zeeuw D, de Jong P, Kreutz R.

J Am Soc Nephrol. 2003 Oct;14(10):2596-602.

31.

A central body fat distribution is related to renal function impairment, even in lean subjects.

Pinto-Sietsma SJ, Navis G, Janssen WM, de Zeeuw D, Gans RO, de Jong PE; PREVEND Study Group.

Am J Kidney Dis. 2003 Apr;41(4):733-41.

PMID:
12666059
32.

Screening for microalbuminuria in the general population: a tool to detect subjects at risk for progressive renal failure in an early phase?

de Jong PE, Hillege HL, Pinto-Sietsma SJ, de Zeeuw D.

Nephrol Dial Transplant. 2003 Jan;18(1):10-3. No abstract available.

PMID:
12480951
33.

Obesity and target organ damage: the kidney.

de Jong PE, Verhave JC, Pinto-Sietsma SJ, Hillege HL; PREVEND study group.

Int J Obes Relat Metab Disord. 2002 Dec;26 Suppl 4:S21-4. Review.

PMID:
12457295
34.

Impaired coronary endothelial function in a rat model of spontaneous albuminuria.

Gschwend S, Pinto-Sietsma SJ, Buikema H, Pinto YM, van Gilst WH, Schulz A, de Zeeuw D, Kreutz R.

Kidney Int. 2002 Jul;62(1):181-91.

35.

Low levels of urinary albumin excretion are associated with cardiovascular risk factors in the general population.

Janssen WM, Hillege H, Pinto-Sietsma SJ, Bak AA, De Zeeuw D, de Jong PE; PREVEND Study Group. Prevention of Renal and Vascular End-stage Disease.

Clin Chem Lab Med. 2000 Nov;38(11):1107-10.

PMID:
11156337
36.

Reduction in left ventricular messenger RNA for transforming growth factor beta(1) attenuates left ventricular fibrosis and improves survival without lowering blood pressure in the hypertensive TGR(mRen2)27 Rat.

Pinto YM, Pinto-Sietsma SJ, Philipp T, Engler S, Kossamehl P, Hocher B, Marquardt H, Sethmann S, Lauster R, Merker HJ, Paul M.

Hypertension. 2000 Nov;36(5):747-54.

PMID:
11082138
37.

Smoking is related to albuminuria and abnormal renal function in nondiabetic persons.

Pinto-Sietsma SJ, Mulder J, Janssen WM, Hillege HL, de Zeeuw D, de Jong PE.

Ann Intern Med. 2000 Oct 17;133(8):585-91.

PMID:
11033585
38.

Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population.

Pinto-Sietsma SJ, Janssen WM, Hillege HL, Navis G, De Zeeuw D, De Jong PE.

J Am Soc Nephrol. 2000 Oct;11(10):1882-8.

39.

Inadequate management of blood pressure in a hypertensive population.

Pinto-Sietsma SJ, Hillege HL, Janssen WM.

N Engl J Med. 1999 May 20;340(20):1593-5. No abstract available.

PMID:
10336363
40.

A role for endothelin in the pathogenesis of hypertension: fact or fiction?

Pinto-Sietsma SJ, Paul M.

Kidney Int Suppl. 1998 Sep;67:S115-21. Review.

PMID:
9736265
41.

Effects of c-myc oncogene modulation on differentiation of human small cell lung carcinoma cell lines.

van Waardenburg RC, Meijer C, Pinto-Sietsma SJ, de Vries EG, Timens W, Mulder NM.

Anticancer Res. 1998 Jan-Feb;18(1A):91-5.

PMID:
9568061
42.

Transgenic rats as models for hypertension.

Pinto-Sietsma SJ, Paul M.

J Hum Hypertens. 1997 Sep;11(9):577-81. Review. No abstract available.

PMID:
9364275

Supplemental Content

Loading ...
Support Center